Furthermore, KIM-1 shows potential as an early diagnostic biomarker for acute kidney injury (AKI) and chronic kidney disease (CKD), offering valuable insights for timely intervention and management in clinical settings. This evidence concerns the gene HAVCR1 and chronic kidney disease.